News | Cath Lab | March 21, 2018

American College of Cardiology Expands Patient Navigator Program

Patient-centered program to focus on reducing myocardial infarction readmissions nationally

American College of Cardiology Expands Patient Navigator Program

March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help improve care and lower readmission rates for myocardial infarction (MI) patients as part of the American College of Cardiology’s expanded Patient Navigator Program: Focus MI Quality Campaign.

With support from founding sponsor AstraZeneca, the expanded program will provide hospitals participating in the ACC’s ACTION Registry the opportunity to transform care by sharing successful strategies, mentorship, and specialized tools and resources. In addition, 15 of the original 35 hospitals from the first phase of the Patient Navigator Program will focus on identifying best practices for improving patient care and readmissions, including 30 and 90 days follow-up post-hospital discharge – an increasing area of focus for proposed payment and reimbursement models.

“Since the original Patient Navigator Program launched, hospitals and cardiovascular care team members have led the way in developing effective ways to help manage patients’ heart health after they leave the hospital,” said ACC President Mary Norine Walsh, M.D., FACC. “The Patient Navigator Program: Focus MI aims to build on what we have learned to help hospitals across the country reduce readmission rates while improving patients’ long-term outcomes.”

A total of 35 U.S. hospitals participated in the initial Patient Navigator Program, which launched in 2013 and focused on reducing 30-day hospital readmissions for MI and heart failure patients. Hospitals participating in the program reported increases in the number of MI patients assessed for risk of readmissions and greater understanding among MI and heart failure patients about their medications. In addition, they were able to reach both groups of patients with education and community resources aimed at ensuring smoother patient transitions from hospital to home. Results were presented in greater detail at ACC’s 67th Annual Scientific Session, March 10-12 in Orlando, Fla.

Hospitals that enroll in the Patient Navigator Program: Focus MI access evidence-based toolkits, self-assessment tools, a learning community of national experts and peer colleagues, and an ACTION Registry dashboard specifically designed to track Patient Navigator Program: Focus MI metrics. The select 15 Diplomat Hospitals, focus on reducing 90-day readmissions for MI patients and provide mentorship for wider adoption of the program across other institutions.

For more information: www.acc.org

 


Related Content

News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
Subscribe Now